Fig. 1From: Concurrent chemoradiotherapy with cisplatin + S-1 versus cisplatin + other third-generation agents for locally advanced non-small-cell lung cancer: a meta-analysis of individual participant dataa The overall survival (OS) and b progression-free survival (PFS) curves by treatment armBack to article page